🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

The ACC has named Viet Le, DMSc, MPAS, PA-C, FACC, to lead its #CardioSmart patient engagement program. "I'm excited to build on my predecessors' work, providing tools for informed decisions & supporting healthy life journeys." - Viet Le DMSc PA-C FACC FAHA HF-Cert Learn more: bit.ly/4d9hBQp

It is more and more common group of #patients, very challenging, therefore we need to know how to treat #lipiddisorders - the most common #CVD risk factor worldwide. Thanks to Prof. Agnieszka Mickiewicz for leading this important project💪 academic.oup.com/ndt/advance-ar…

Truly a masterclass presentation by Keith C. Ferdinand, MD, FACC, FAHA, FNLA on improving management of HTN! From tips on proper measurement to the role of diet, supplements, home BP monitoring, and safe/effective treatments, this webinar had it all! 🙏🏻 ASPC for hosting! Michael D. Shapiro Dr. Martha Gulati ♥️🫀❤️‍🩹🇨🇦

Been listening to CardioNerds for 3 years - finally got to round with the legend himself, Amit Goyal MD MAS! 🔥 He walks the walk, lives the mission, and makes learning cardiology seriously fun. Infectious energy and endless pearls🫀🎙️

🚨 Coming soon in Atherosclerosis ! A powerful new review explores the link between adipose tissue dysfunction and atherosclerosis, shedding light on innovative therapies. This comprehensive review explores the complex interplay between adipose tissue dysfunction and

Harpreet Bhatia Zeina Dardari Anurag Mehta Khurram Nasir Ron Blankstein Ijeoma Isiadinso MD MPH FACC FASNC AQuyyumi Viola Vaccarino Jonathan Fialkow Muin J. Khoury FCoronado Matthew Budoff MD Roger Blumenthal Seamus Whelton Martin Bødtker Mortensen LSperling Kuni Matsushita Michael J. Blaha Omar Dzaye

Outstanding review led by former The Osler Medical Residency ⭐️ & Michigan Football insider JaredSpitzMD + ASPC President Michael D. Shapiro

An absolute risk generalizable risk calculator is challenging. Led by So Mi Jemma Cho, evaluating AHA PREVENT across 4 academic health systems, we found similar discrimination but variable calibration. A universal absolute risk threshold may not suitably guide.

ASPC Khurram Nasir AJPC 👏🏻👏🏻

☝️No estimate of the apoB lipoprotein-related risk of CVD is complete without measurement of both apoB and Lp(a) ApoB is the true core marker of atherogenic particle burden, and Lp(a) is an independent, non-negotiable player in cardiovascular risk. ✅ ApoB reflects the number

Welcome ASPC onboard .

Amazing lecture by Keith C. Ferdinand, MD, FACC, FAHA, FNLA , not to be missed!

Video summary of our recent paper on the AHA PREVENT equations and Lp(a) JAMA Cardiology Vumedi Cardio UC San Diego Cardiology: vumedi.com/video/lpa-and-…

Our comprehensive review on novel hypertriglyceridemia treatments to address ASCVD published in the American Journal of Cardiovascular Drugs 🫀 Abdul Mannan Khan Minhas Salim Virani Dmitry Abramov Mahmoud Ismayl, M.D. Sachin Parikh Arunima Misra 🔗: link.springer.com/article/10.100…

The best record in baseball belongs to your Chicago Cubs.

Happy to be a contributing author on this review discussing the role of Lp(a) in South Asian adults, led by Dinesh Kalra, MD We review data on Lp(a) in mediating ASCVD, epidemiology in SA, screening guidelines, & meds to reduce Lp(a)/associated CVD risk 🔗 ahajournals.org/doi/10.1161/JA…

Excited for my second ASPC meeting this year! Do not miss three days filled with top discussions in #PreventiveCardiology 🫀 The countdown for #ASPC2025 has started!!!

Cardiovascular Disease Fellowship Program Inova Schar Heart and Vascular Honored to train the next leaders in the field · World Class Faculty · Dedicated Mentoring · Complex Patient Care · Outstanding Research Opportunities · Commitment to Innovation and Excellence vimeo.com/1098619654

Outstanding CV training program geared towards building the next generation of leaders in cardiology 🫀 Inova Schar Heart and Vascular Christopher O'Connor Jamie Kennedy #ACCFIT #ACCFIT vimeo.com/1098619654

In this population-based cohort study of statin initiators, most had a repeat lipid panel within a year. Findings highlight residual risk from incomplete LDL-C or non-HDL-C control after starting statins for primary prevention. jacc.org/doi/10.1016/j.… #JACCAdvances #cvLipids